Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy

by Thomsen C, Theilig D, Herzog D, Poellinger A, Doellinger F, Schreiter N, Schreiter V, Schürmann D, Temmesfeld-Wollbrueck B, Hippenstiel S, Suttorp N, Hubner RH
Published 2016-06-01

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals

by Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK
Published 2010-03-01

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

by Ellefsen-Lavoie K, Rockstroh J, Pollard R, Pantaleo G, Podzamczer D, Asmuth D, van Lunzen J, Arastéh K, Schürmann D, Peters B, Clotet B, Hardy D, Lazzarin A, Gatell J, Sommerfelt MA, Baksaas I, Wendel-Hansen V, Sørensen B
Published 2012-09-01